21572126

Source:http://linkedlifedata.com/resource/pubmed/id/21572126

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018801, umls-concept:C0026565, umls-concept:C0030705, umls-concept:C0062534, umls-concept:C0205179, umls-concept:C0442821, umls-concept:C2698872
pubmed:issue	14
pubmed:dateCreated	2011-6-20
pubmed:abstractText	To assess the prognostic value of the mitogenic, antiapoptotic, angiogenic and antifibrotic hepatocyte growth factor (HGF) in heart failure (HF).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/HGF protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Natriuretic Peptide, Brain
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1468-201X
pubmed:author	pubmed-author:BergerRudolfR, pubmed-author:HülsmannMartinM, pubmed-author:HohensinnerPhilipp JPJ, pubmed-author:HuberKurtK, pubmed-author:Kariem MahdyAliA, pubmed-author:MörtlDeddoD, pubmed-author:NeuholdStephanieS, pubmed-author:NiessnerAlexanderA, pubmed-author:PacherRichardR, pubmed-author:RichterBernhardB, pubmed-author:RychliKathrinK, pubmed-author:WojtaJohannJ, pubmed-author:ZornGerlindeG
pubmed:issnType	Electronic
pubmed:volume	97
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1158-63
pubmed:meshHeading	pubmed-meshheading:21572126-Aged, pubmed-meshheading:21572126-Aged, 80 and over, pubmed-meshheading:21572126-Austria, pubmed-meshheading:21572126-Biological Markers, pubmed-meshheading:21572126-Chi-Square Distribution, pubmed-meshheading:21572126-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:21572126-Female, pubmed-meshheading:21572126-Heart Failure, pubmed-meshheading:21572126-Hepatocyte Growth Factor, pubmed-meshheading:21572126-Humans, pubmed-meshheading:21572126-Kaplan-Meier Estimate, pubmed-meshheading:21572126-Linear Models, pubmed-meshheading:21572126-Male, pubmed-meshheading:21572126-Middle Aged, pubmed-meshheading:21572126-Myocardial Ischemia, pubmed-meshheading:21572126-Natriuretic Peptide, Brain, pubmed-meshheading:21572126-Predictive Value of Tests, pubmed-meshheading:21572126-Prognosis, pubmed-meshheading:21572126-Proportional Hazards Models, pubmed-meshheading:21572126-Risk Assessment, pubmed-meshheading:21572126-Risk Factors, pubmed-meshheading:21572126-Up-Regulation
pubmed:year	2011
pubmed:articleTitle	Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
pubmed:affiliation	Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't